Clough Capital Partners L P Decreases Stock Holdings in Encompass Health Corporation $EHC

Clough Capital Partners L P decreased its stake in shares of Encompass Health Corporation (NYSE:EHC) by 6.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 95,501 shares of the company’s stock after selling 6,280 shares during the period. Clough Capital Partners L P owned about 0.09% of Encompass Health worth $12,131,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Citizens National Bank Trust Department bought a new position in shares of Encompass Health during the 3rd quarter valued at $26,000. First Horizon Corp bought a new stake in shares of Encompass Health in the third quarter worth $34,000. Westside Investment Management Inc. grew its holdings in shares of Encompass Health by 56.7% in the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after acquiring an additional 101 shares during the period. Assetmark Inc. increased its position in Encompass Health by 88.1% during the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock valued at $38,000 after acquiring an additional 140 shares during the last quarter. Finally, Root Financial Partners LLC bought a new position in Encompass Health in the third quarter valued at about $39,000. Institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the subject of a number of recent research reports. Barclays boosted their price target on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research note on Friday, February 6th. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Finally, Zacks Research downgraded shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $143.29.

Insiders Place Their Bets

In other Encompass Health news, CEO Mark J. Tarr sold 150,000 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the sale, the chief executive officer directly owned 377,070 shares of the company’s stock, valued at $42,096,094.80. This trade represents a 28.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Treasurer Edmund Fay sold 11,937 shares of the business’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the transaction, the treasurer owned 89,325 shares in the company, valued at $9,557,775. The trade was a 11.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 2.00% of the stock is currently owned by insiders.

Encompass Health Trading Up 0.2%

Shares of NYSE:EHC opened at $100.52 on Friday. The stock has a 50 day moving average of $103.58 and a 200 day moving average of $112.98. The company has a market cap of $9.99 billion, a PE ratio of 18.14, a price-to-earnings-growth ratio of 1.92 and a beta of 0.71. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 5th. The company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. The company had revenue of $3.09 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The firm’s revenue was up 9.9% compared to the same quarter last year. During the same quarter last year, the business earned $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, equities research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Wednesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is presently 13.72%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.